Notify me when Aptus Capital Advisors, LLC files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 1,631 | $11,768,225,366 | +$1,599,536,631 | -$795,773,998 | +$803,762,633 | ACIO, DRSK, VXUS, NVDA, AAPL | 13F-HR | 13 Feb 2026, 12:23 |
| Q3 2025 | 1,564 | $10,953,319,783 | +$927,852,754 | -$651,171,874 | +$276,680,880 | ACIO, DRSK, NVDA, AAPL, MSFT | 13F-HR | 12 Nov 2025, 16:33 |
| Q2 2025 | 1,519 | $10,122,618,299 | +$1,306,213,686 | -$603,759,545 | +$702,454,141 | ACIO, DRSK, NVDA, MSFT, AAPL | 13F-HR | 11 Aug 2025, 10:25 |
| Q1 2025 | 1,431 | $8,822,347,766 | +$1,130,422,504 | -$521,886,440 | +$608,536,064 | ACIO, DRSK, AAPL, MSFT, NVDA | 13F-HR | 13 May 2025, 16:43 |
| Q4 2024 | 1,402 | $8,401,546,146 | +$2,119,261,312 | -$402,832,134 | +$1,716,429,178 | ACIO, DRSK, AAPL, MSFT, NVDA | 13F-HR | 14 Feb 2025, 16:22 |
| Q3 2024 | 1,231 | $6,527,871,521 | +$1,216,162,962 | -$167,335,906 | +$1,048,827,056 | ACIO, DRSK, AAPL, OSCV, MSFT | 13F-HR | 05 Nov 2024, 16:33 |
| Q2 2024 | 1,159 | $5,230,832,612 | +$872,695,683 | -$252,799,860 | +$619,895,823 | ACIO, DRSK, MSFT, OSCV, AAPL | 13F-HR | 31 Jul 2024, 16:55 |
| Q1 2024 | 1,162 | $4,656,899,714 | +$1,183,116,844 | -$138,692,396 | +$1,044,424,448 | ACIO, DRSK, OSCV, JUCY, MSFT | 13F-HR | 15 May 2024, 16:22 |
| Q4 2023 | 913 | $3,382,874,271 | +$202,532,987 | -$548,086,905 | -$345,553,918 | ACIO, DRSK, OSCV, AAPL, MSFT | 13F-HR | 13 Feb 2024, 14:58 |
| Q3 2023 | 896 | $3,422,308,529 | +$679,148,848 | -$564,375,374 | +$114,773,474 | ACIO, DRSK, OSCV, AAPL, DUBS | 13F-HR | 08 Nov 2023, 14:33 |
| Q2 2023 | 781 | $3,422,895,668 | +$225,517,956 | -$436,376,212 | -$210,858,256 | ACIO, DRSK, OSCV, AAPL, ADME | 13F-HR | 11 Aug 2023, 10:13 |
| Q1 2023 | 785 | $3,505,578,292 | +$683,312,554 | -$343,679,386 | +$339,633,168 | DRSK, ACIO, ADME, OSCV, IBDT | 13F-HR | 09 May 2023, 15:19 |
| Q4 2022 | 791 | $3,044,746,447 | +$422,866,941 | -$668,400,476 | -$245,533,535 | DRSK, ACIO, IBDS, ADME, IBDT | 13F-HR | 13 Feb 2023, 16:13 |
| Q3 2022 | 761 | $3,133,901,000 | +$598,628,220 | -$294,265,444 | +$304,362,776 | DRSK, ACIO, ADME, IBDS, BSCP | 13F-HR | 02 Nov 2022, 11:49 |
| Q2 2022 | 650 | $3,002,697,000 | +$985,635,692 | -$892,584,240 | +$93,051,452 | DRSK, ACIO, IBDS, BSCP, BSCQ | 13F-HR | 29 Jul 2022, 14:54 |
| Q1 2022 | 672 | $3,250,798,000 | +$680,675,287 | -$250,188,906 | +$430,486,381 | DRSK, IBDQ, IBDO, IBDR, ACIO | 13F-HR | 04 May 2022, 12:36 |
| Q4 2021 | 547 | $2,948,442,000 | +$429,328,622 | -$139,268,194 | +$290,060,428 | DRSK, IBDO, IBDQ, IBDP, ACIO | 13F-HR | 02 Feb 2022, 15:03 |
| Q3 2021 | 519 | $2,533,224,000 | +$536,651,014 | -$175,733,237 | +$360,917,777 | DRSK, IBDO, IBDN, IBDP, ACIO | 13F-HR | 27 Oct 2021, 16:33 |
| Q2 2021 | 544 | $2,195,726,000 | +$248,008,625 | -$46,312,077 | +$201,696,548 | DRSK, IBDO, ADME, ACIO, IBDN | 13F-HR | 27 Jul 2021, 13:18 |
| Q1 2021 | 497 | $1,920,954,000 | +$295,726,086 | -$105,954,548 | +$189,771,538 | DRSK, IBDO, ACIO, ADME, IBDN | 13F-HR | 06 May 2021, 14:38 |
| Q4 2020 | 453 | $1,695,753,000 | +$361,534,792 | -$125,780,708 | +$235,754,084 | DRSK, ADME, ACIO, IBDO, IBDN | 13F-HR | 10 Feb 2021, 15:12 |
| Q3 2020 | 440 | $1,405,249,000 | +$228,088,493 | -$49,087,924 | +$179,000,569 | DRSK, ADME, ACIO, IBDO, IBDQ | 13F-HR | 16 Oct 2020, 17:40 |
| Q2 2020 | 396 | $1,196,081,000 | +$260,242,514 | -$147,567,801 | +$112,674,713 | DRSK, ACIO, ADME, IBDO, IBDQ | 13F-HR | 22 Jul 2020, 10:21 |
| Q1 2020 | 392 | $978,552,000 | +$348,095,371 | -$259,560,417 | +$88,534,954 | DRSK, ACIO, ADME, BSCK, BSCL | 13F-HR | 07 May 2020, 10:40 |
| Q4 2019 | 447 | $982,841,000 | +$271,233,774 | -$190,989,629 | +$80,244,145 | DRSK, ACIO, ADME, OSCV, IBDR | 13F-HR | 10 Feb 2020, 13:53 |
| Q3 2019 | 425 | $876,462,000 | +$280,818,510 | -$115,925,716 | +$164,892,794 | DRSK, ACIO, FTVA, ADME, OSCV | Restatement | 14 Nov 2019, 17:15 |
| Q2 2019 | 318 | $703,815,000 | +$166,498,687 | -$56,359,837 | +$110,138,850 | DRSK, FTVA, ADME, OSCV, SPDW | 13F-HR | 12 Aug 2019, 17:55 |
| Q1 2019 | 294 | $578,728,000 | +$303,328,852 | -$121,727,424 | +$181,601,428 | DRSK, FTVA, ADME, OSCV, IBDR | 13F-HR | 15 May 2019, 16:18 |
| Q4 2018 | 161 | $374,989,000 | $0 | $0 | $0 | DRSK, IEF, FTVA, ETF SER SOLUTIONS, SHY | 13F-HR | 12 Feb 2019, 15:07 |